H
Heiko Pohl
Researcher at Dartmouth–Hitchcock Medical Center
Publications - 116
Citations - 4677
Heiko Pohl is an academic researcher from Dartmouth–Hitchcock Medical Center. The author has contributed to research in topics: Medicine & Colonoscopy. The author has an hindex of 20, co-authored 80 publications receiving 4141 citations. Previous affiliations of Heiko Pohl include Veterans Health Administration & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence
Heiko Pohl,H. Gilbert Welch +1 more
TL;DR: The rising incidence of esophageal adenocarcinoma represents a real increase in disease burden and overdiagnosis can be excluded as an explanation for the rise in incidence.
Journal ArticleDOI
Incomplete Polyp Resection During Colonoscopy—Results of the Complete Adenoma Resection (CARE) Study
Heiko Pohl,Heiko Pohl,Amitabh Srivastava,Steve P. Bensen,Peter B. Anderson,Richard I. Rothstein,Stuart R. Gordon,L. Campbell Levy,Arifa Toor,Todd MacKenzie,Thomas Rösch,Douglas J. Robertson,Douglas J. Robertson +12 more
TL;DR: Neoplastic polyps are often incompletely resected, and the rate of incomplete resection varies broadly among endoscopists, and efforts are needed to ensure complete resection, especially of larger lesions.
Journal ArticleDOI
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps.
Douglas K. Rex,Charles J. Kahi,Michael J. O'Brien,Theodore R. Levin,Heiko Pohl,Amit Rastogi,Larry Burgart,Tom Imperiale,Uri Ladabaum,Jonathan Cohen,David A. Lieberman +10 more
TL;DR: The following document, or PIVI, is one of a series of statements defining the diagnostic or therapeutic threshold that must be met for a technique or device to become considered appropriate for incorporation into clinical practice.
Journal ArticleDOI
Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?
TL;DR: The incidence of early stage esophageal adenocarcinoma seems to have plateaued, and although definitive conclusions will require additional years of data, the plateau in early stage disease might portend stabilization in the overall incidence of esoph age-related cancer.
Journal ArticleDOI
Prevalence of clinically important histology in small adenomas.
TL;DR: Adenomas 5-10 mm in size harbor pathologically significant histology, and the need for removal of these lesions must be addressed to optimize colorectal cancer prevention.